“Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer”. Journal of Cancer Research Updates 11 (October 27, 2022): 63–69. Accessed April 16, 2026. https://www.neoplasiaresearch.com/index.php/jcru/article/view/691.